The single-dose jab was found to generate 'robust protective' immune responses against the highly infectious variants, including the one in South Africa, a new study found.
89bio Inc (ETNB) Begins Phase 2b ENLIVEN Trial of BIO89-100 for Treatment of NASH streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
In the three months since Johnson & Johnson's COVID-19 vaccine received emergency use authorization from the U.S. Food and Drug Administration, more than 10 million Americans have received the vaccine, according to the Centers for Disease Control and Prevention.